MicroED Structures of Fluticasone Furoate and Fluticasone Propionate Provide New Insights into Their Function

被引:0
|
作者
Lin, Jieye [1 ]
Unge, Johan [2 ]
Gonen, Tamir [1 ]
机构
[1] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA
[2] Umea Univ, Dept Chem, Umea 90178, Sweden
基金
美国国家卫生研究院;
关键词
GLUCOCORTICOID-RECEPTOR; LIGAND-BINDING; TRANSLOCATION; PERFORMANCE; ENERGIES; INHALER; ATOMS; SET;
D O I
10.1021/acs.cgd.4c01683
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The detailed understanding of the conformational pathway of fluticasone, a widely prescribed medicine for allergic rhinitis, asthma, and chronic obstructive pulmonary disease (COPD), from formulation to its protein-bound state, has been limited due to a lack of access to its high-resolution structures. The three-dimensional (3D) structure of fluticasone furoate 1 remains unpublished, and the deposited structure of fluticasone propionate 2 could be further refined due to refinement against new data. We applied microcrystal electron diffraction (MicroED) to determine the 3D structures of 1 and 2 in their solid states. The preferred geometries in solution were predicted by using density functional theory (DFT) calculations. A comparative analysis of the structures of 1 and 2 across three states (in solid state, in solution, and protein-bound conformation) revealed the course of the conformational changes during the entire transition. Potential energy plots were calculated for the most dynamic bonds, uncovering their rotational barriers. This study underscores the combined use of MicroED and DFT calculations to provide a comprehensive understanding of conformational and energy changes during drug administration. The quantitative comparison also highlights the subtle structural differences that may lead to significant changes in the pharmaceutical properties.
引用
收藏
页码:1588 / 1596
页数:9
相关论文
共 50 条
  • [31] Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma A Randomized Trial
    Woodcock, Ashley
    Bleecker, Eugene R.
    Lotvall, Jan
    O'Byrne, Paul M.
    Bateman, Eric D.
    Medley, Hilary
    Ellsworth, Anna
    Jacques, Loretta
    Busse, William W.
    CHEST, 2013, 144 (04) : 1222 - 1229
  • [32] Do patients on fluticasone furoate (FF), mometasone furoate (MF) and fluticasone propionate (FP) experience similar numbers of symptom free days and quality of life in three European countries
    Gueron, B.
    Demoly, P.
    Piercy, J.
    Small, M.
    ALLERGY, 2010, 65 : 156 - 156
  • [33] Fluticasone Furoate, a Novel Enhanced-affinity Inhaled Corticosteroid, is More Potent than Fluticasone Propionate and Budesonide in Human Respiratory Cell Lines
    To, Y.
    Rossios, C.
    Barnes, P. J.
    Adcock, I. M.
    Johnson, M.
    Ito, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [34] Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) compared with fluticasone propionate/salmeterol combination (FP/SAL) in adults and adolescents with persistent asthma
    Woodcock, Ashley
    Bleecker, Eugene R.
    Lotvall, Jan
    O'Byrne, Paul M.
    Bateman, Eric D.
    Medley, Hilary
    Ellsworth, Anna
    Jacques, Loretta
    Busse, William W.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [35] Pharmacokinetics, Safety, and Tolerability of a New Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate Diskus® in Healthy Adults
    Vutikullird, Apinya Bee
    Gillespie, Michael
    Song, Sharon
    Steinfeld, Jonathan
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2016, 29 (02) : 207 - 214
  • [36] Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate
    Tayab, Zia R.
    Fardon, Tom C.
    Lee, Daniel K. C.
    Haggart, Kay
    McFarlane, Lesley C.
    Lipworth, Brian J.
    Hochhaus, Gunther
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (05) : 698 - 705
  • [37] Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants
    Ponsioen, BP
    Bohnen, AM
    Dekhuijzen, PNR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (07) : 930 - 930
  • [38] Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants
    Hofhuis, W
    van der Wiel, EC
    Nieuwhof, EM
    Hop, WCJ
    Affourtit, MJ
    Smit, FJ
    Vaessen-Verberne, AAPH
    Versteegh, FGA
    Jongste, JC
    Merkus, PJFM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (04) : 328 - 333
  • [39] Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
    Belchamber, Kylie B. R.
    Thomas, Catherine M. R.
    Dunne, Amy E.
    Barnes, Peter J.
    Donnelly, Louise E.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 2883 - 2897
  • [40] Comparable in vivo anti-inflammatory potency at trough using inhaled fluticasone furoate and propionate
    van den Berge, M.
    Luijk, B.
    Bareille, P.
    Dallow, N.
    Postma, D. S.
    Lammers, J-W. J.
    ALLERGY, 2011, 66 (05) : 699 - 700